Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H8O3 |
Molecular Weight | 188.1794 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)C1=CC2=CC=CC=C2C=C1O
InChI
InChIKey=ALKYHXVLJMQRLQ-UHFFFAOYSA-N
InChI=1S/C11H8O3/c12-10-6-8-4-2-1-3-7(8)5-9(10)11(13)14/h1-6,12H,(H,13,14)
Molecular Formula | C11H8O3 |
Molecular Weight | 188.1794 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0034976 Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Inactive ingredient | ALCOPAR Approved UseHelminthiasis |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645
In a preclinical study, mice received hydroxynaphthoic acid sodium salt (150 mg/kg/day) twice a day for 2 weeks by gavage.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/26983645
The stable HEK 293 cell line harboring a reporter gene expressed by human grp78 promoter was treated with PA media containing 300 uM of palmitate to induce ER stress and then serial dilutions of hydroxynaphthoic acid were applied (from 0.01 to 1 mM) for 22 h. The drug inhibited ER stress with IC50 value of 44.9 uM. It also reduced PA-induced p-JNK and p-IRS-1(S307) levels in dose-dependent manners in HepG2 cells when incubated for 2 h at concentrations 0.1, 0.3, 0.5 mM. At 0.3 mM hydroxynaphthoic acid restored insulin sensitivity suppressed by PA. When fully differentiated 3T3-L1 cells were co-incubated with or without thapsigargin (Tg) and hydroxynaphthoic acid (30, 100, 300 uM) for 18 h, the acid augmented GLUT4 translocation by sensitizing insulin and PPARgamma signaling and showed 100-fold activation at 300 uM. The drug (0.1 and 0.3 mM) protected INS-1 cells from cell death after the incubation with 300 uM PA in combination with 25 mM glucose for 18 h.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:51:31 GMT 2023
by
admin
on
Fri Dec 15 15:51:31 GMT 2023
|
Record UNII |
C7S9D784HX
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3719
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
C7S9D784HX
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
5278
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
3-Hydroxy-2-naphthoic acid
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
92-70-6
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
m6144
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID3026560
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
C021303
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
1148238
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
202-180-8
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY | |||
|
7104
Created by
admin on Fri Dec 15 15:51:31 GMT 2023 , Edited by admin on Fri Dec 15 15:51:31 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |